{
    "title": "KalVista shares sink after ending drug trial for hereditary disease",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11278999/KalVista-shares-sink-ending-drug-trial-hereditary-disease.html",
    "date": "2022-10-04",
    "keywords": [
        "drug",
        "midstage",
        "trial",
        "disease",
        "tuesday",
        "study",
        "recurrent",
        "safety",
        "developer",
        "liver",
        "damage",
        "termination",
        "formulation",
        "bestinclass",
        "therapy",
        "chief",
        "executive",
        "crockett",
        "year",
        "information",
        "angioedema",
        "swelling",
        "skin",
        "membrane",
        "csl",
        "behring",
        "biocryst",
        "work",
        "kalvista",
        "sebetralstat",
        "edema",
        "cambridge",
        "company",
        "premarket",
        "trading",
        "reporting",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "dsouza",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}